The stock of Adverum Biotechnologies Incorporated (NASDAQ:ADVM) registered a decrease of 9.48% in short interest. ADVM’s total short interest was 661,100 shares in September as published by FINRA. Its down 9.48% from 730,300 shares, reported previously. With 111,300 shares average volume, it will take short sellers 6 days to cover their ADVM’s short positions. The short interest to Adverum Biotechnologies Incorporated’s float is 2.36%. About 151,773 shares traded hands. Adverum Biotechnologies Inc (NASDAQ:ADVM) has declined 3.58% since February 8, 2016 and is downtrending. It has underperformed by 20.07% the S&P500.
Adverum Biotechnologies, Inc., formerly Avalanche Biotechnologies, Inc., is a gene therapy company. The company has a market cap of $164.02 million. The Firm is engaged in discovering and developing medicines to patients suffering from chronic or debilitating disease. It currently has negative earnings. The Firm operates and manages its business in the segment of developing and commercializing gene therapeutics.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.